The Role of Properdin in Zymosan- and Escherichia coli-Induced Complement Activation

Por Harboe, Morten, Garred, Peter, Lindstad, Julie K., Pharo, Anne, Müller, Fredrik, Stahl, Gregory L., Lambris, John D., Mollnes, Tom Eirik
Publicado em 2012

Post challenge inhibition of C3 and CD14 attenuates Escherichia coli-induced inflammation in human whole blood

Por Egge, Kjetil H, Thorgersen, Ebbe B, Lindstad, Julie K, Pharo, Anne, Lambris, John D, Barratt-Due, Andreas, Mollnes, Tom E
Publicado no Innate Immun (2013)

The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load

Por Egge, Kjetil H, Barratt-Due, Andreas, Nymo, Stig, Lindstad, Julie K, Pharo, Anne, Lau, Corinna, Espevik, Terje, Thorgersen, Ebbe B, Mollnes, Tom E
Publicado no Clin Exp Immunol (2015)

Properdin binding to complement activating surfaces depends on initial C3b deposition

Por Harboe, Morten, Johnson, Christina, Nymo, Stig, Ekholt, Karin, Schjalm, Camilla, Lindstad, Julie K., Pharo, Anne, Hellerud, Bernt Christian, Nilsson Ekdahl, Kristina, Mollnes, Tom Eirik, Nilsson, Per H.
Publicado no Proc Natl Acad Sci U S A (2017)

Chimeric Anti-CD14 IGG2/4 Hybrid Antibodies for Therapeutic Intervention in Pig and Human Models of Inflammation

Por Lau, Corinna, Gunnarsen, Kristin S., Høydahl, Lene S., Andersen, Jan Terje, Berntzen, Gøril, Pharo, Anne, Lindstad, Julie K., Ludviksen, Judith K., Brekke, Ole-Lars, Barratt-Due, Andreas, Nielsen, Erik Waage, Stokes, Christopher R., Espevik, Terje, Sandlie, Inger, Mollnes, Tom Eirik
Publicado em 2013